Stockscreener 앱 받기
2.67
1.48%
-0.04
전일 마감가:
$2.71
열려 있는:
$2.71
하루 거래량:
28,903
Relative Volume:
0.60
시가총액:
$49.94M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-0.74%
1개월 성능:
+3.49%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$2.54
$2.71
1주일 범위
$2.46
$2.7932
52주 변동 폭
$2.28
$12.50
Kalaris Therapeutics Inc Stock (KLRS) Company Profile
명칭
Kalaris Therapeutics Inc
전화
650-249-2727
주소
628 MIDDLEFIELD ROAD, PALO ALTO
KLRS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KLRS
Kalaris Therapeutics Inc
|
2.67 | 49.37M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Kalaris Therapeutics Inc Stock (KLRS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-23 | 재개 | Piper Sandler | Neutral |
| 2025-05-07 | 개시 | Leerink Partners | Outperform |
| 2025-04-08 | 개시 | William Blair | Outperform |
Kalaris Therapeutics Inc 주식(KLRS)의 최신 뉴스
Using AI based signals to follow Kalaris Therapeutics Inc.Strategy Builder for Growth Focused Traders - Newser
Why Kalaris Therapeutics Inc. stock attracts strong analyst attentionIntelligent Trade Forecast With AI Analytics - Newser
Multi asset correlation models including Kalaris Therapeutics Inc.Real Time Trade Execution Alert Plan - Newser
Can swing trading help recover from Kalaris Therapeutics Inc. lossesFast Movement Forecast for Trading Success - Newser
Has Kalaris Therapeutics Inc. formed a bullish divergenceConservative Asset Allocation Risk Analysis - Newser
Automated trading signals detected on Kalaris Therapeutics Inc.AI Powered Buy Point Forecast Planner - Newser
Using economic indicators to assess Kalaris Therapeutics Inc. potentialChart Confirmation Setup with ROI Signals - Newser
What makes Kalaris Therapeutics Inc. stock price move sharplyDividend Strategy Summary With 10-Year Outlook - Newser
Is Kalaris Therapeutics Inc. stock a good hedge against inflationAnnual Market Behavior and Sector Summary - Newser
Is Kalaris Therapeutics Inc. stock entering bullish territoryDownside Risk Evaluation and Stock Analysis - Newser
Will Kalaris Therapeutics Inc. bounce back from current supportDaily Exit and Entry Price Prediction - Newser
How to integrate Kalaris Therapeutics Inc. into portfolio analysis toolsAI Entry Timing Prediction for Swing Traders - Newser
Using Ichimoku Cloud for Kalaris Therapeutics Inc. technicalsReliable Setup Screener with Low Risk - Newser
Should I buy Kalaris Therapeutics Inc. stock before earningsAlpha Trade Flow With Risk Calibration - Newser
Will Kalaris Therapeutics Inc. continue its uptrendMachine Learning Stock Price Forecast Tool - Newser
What moving averages say about Kalaris Therapeutics Inc.AI Short-Term Gain Forecast with Data - Newser
Kalaris KLRS 2025Q2 Earnings Preview Upside Potential on Analyst Price Target Predictions - AInvest
Applying Elliott Wave Theory to Kalaris Therapeutics Inc.Watchlist Summary for Active Day Traders - Newser
What analysts say about Kalaris Therapeutics Inc. stockHigh-yield trading alerts - Jammu Links News
How volatile is Kalaris Therapeutics Inc. stock compared to the marketUnlock powerful trading tools for investors - Jammu Links News
Is it the right time to buy Kalaris Therapeutics Inc. stockInvest confidently with data-driven strategies - Jammu Links News
What is the risk reward ratio of investing in Kalaris Therapeutics Inc. stockNavigate the market with precision insights - Jammu Links News
How many analysts rate Kalaris Therapeutics Inc. as a “Buy”Consistently superior profits - Jammu Links News
Why is Kalaris Therapeutics Inc. stock attracting strong analyst attentionExceptional stock performance - Jammu Links News
What institutional investors are buying Kalaris Therapeutics Inc. stockCapitalize on trading strategies that deliver - Jammu Links News
What are the latest earnings results for Kalaris Therapeutics Inc.High-velocity gains - Jammu Links News
What drives Kalaris Therapeutics Inc. stock priceDynamic investment growth - Jammu Links News
Statistical indicators supporting Kalaris Therapeutics Inc.’s strengthShort-Term Sector Movement Forecast Generator - Newser
Does Kalaris Therapeutics Inc. stock perform well during market downturnsInvest confidently with professional advice - Jammu Links News
Should I hold or sell Kalaris Therapeutics Inc. stock in 2025Real-time trading signals for maximum returns - Jammu Links News
What is Kalaris Therapeutics Inc. company’s growth strategyBuild wealth with high-performing stocks - Jammu Links News
Is Kalaris Therapeutics Inc. a growth stock or a value stockFree Consultation - Jammu Links News
Kalaris Therapeutics Inc (KLRS) 재무 분석
Kalaris Therapeutics Inc (KLRS)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):